A Study of PTR-01 in Recessive Dystrophic Epidermolysis Bullosa
Status:
Completed
Trial end date:
2021-09-01
Target enrollment:
Participant gender:
Summary
Protocol PTR-01-002 is a 3-part Phase 2, open-label study of PTR-01. While new patients will
be enrolled, priority will be given to patients that satisfactorily completed study
PTR-01-001.